An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison.Watch more: 🎥 https://t.co/2foNhUN4Ir https://t.co/yinNXgHjyU ...

Aspen Pharmacare secured the rights to develop, manufacture and sell potentially the world’s first monthly oral pill to prevent HIV, positioning South Africa at the forefront of efforts to combat the virus. https://t.co/tr5StE3O5z ...